Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
| Status: | Completed |
|---|---|
| Conditions: | Depression, Schizophrenia, Major Depression Disorder (MDD), Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/2/2016 |
| Start Date: | November 1998 |
| End Date: | January 2012 |
| Contact: | Barrett Share, M.A. |
| Email: | daniel.b.share@vanderbilt.edu |
| Phone: | 615-936-6796 |
The goals of this study are to replicate previous findings of genetic predictors of response
to clozapine and other antipsychotic drugs.
to clozapine and other antipsychotic drugs.
Inclusion Criteria:
Patients with the diagnoses of schizophrenia or schizoaffective disorder, and bipolar
disorder or major depression with psychotic features, or volunteers with no history of a
psychotic disorder.
Exclusion Criteria:
Patients with DSM-IV diagnoses other than schizophrenia or schizoaffective disorder, and
bipolar disorder or major depression with psychotic features.
We found this trial at
1
site
Click here to add this to my saved trials
